In the works: Priority list of who will get Covid vaccine first

The Centre has also contacted five domestic and three multinational vaccine makers to understand how soon a candidate vaccine against Covid-19 will be ready. Image used for representational......

How long before the world gets a COVID-19 vaccine?

More than 2 million people have been diagnosed with coronavirus across the world, and the pharmaceutical industry is pulling out all stops to find potential treatments and vaccines for the global......

Why finding COVID-19 vaccine won't be enough to end pandemic

Medical experts have warned that the volume of vaccine available to fight the coronavirus or SARS-CoV-2 in coming years is expected to fall far short of global demand, despite an unprecedented......

Covid Vaccine IP: How Big Pharma lobbied against India

Communications between the USTR and the world's most powerful pharmaceutical and trade lobbying groups reveal that many raised concerns about India's push to exempt Covid vaccines from intellectual......

Sanofi-aventis to buy Genzyme

Ending months of uncertainty, French pharma major Sanofi-aventis said on Wednesday it will buy US biotechnology giant Genzyme Corp for more than $20 billion.The proposed deal has been dragging due......

MNCs look towards India for a booster dose

In recent months, several pharma multinational corporations (MNCs) are increasingly turning to Indian companies to expand market reach in the country’s pharmaceuticals sector. Illustration:......

Should Mallya continue on the Sanofi board?

If Vijay Mallya faces allegations of financial irregularities and has been asked by the new owner, Diageo, to step down from United Spirits’ board, is it appropriate for other companies to......

Sanofi extends USD 18.5 bn bid for Genzyme

Sanofi-aventis on Mondaysaid it has extended its $18.5 billion offer for Genzyme for the second time, a move that will give the French drug-maker additional time to reach an agreement with US......